662 related articles for article (PubMed ID: 22999011)
1. In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not.
Younossi ZM; Otgonsuren M; Venkatesan C; Mishra A
Metabolism; 2013 Mar; 62(3):352-60. PubMed ID: 22999011
[TBL] [Abstract][Full Text] [Related]
2. Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population.
Stepanova M; Younossi ZM
Clin Gastroenterol Hepatol; 2012 Jun; 10(6):646-50. PubMed ID: 22245962
[TBL] [Abstract][Full Text] [Related]
3. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
Stepanova M; Rafiq N; Younossi ZM
Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
[TBL] [Abstract][Full Text] [Related]
4. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease.
Ong JP; Pitts A; Younossi ZM
J Hepatol; 2008 Oct; 49(4):608-12. PubMed ID: 18682312
[TBL] [Abstract][Full Text] [Related]
5. Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey.
Hong HC; Lee JS; Choi HY; Yang SJ; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Metabolism; 2013 Sep; 62(9):1305-12. PubMed ID: 23643404
[TBL] [Abstract][Full Text] [Related]
6. Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.
Gaharwar R; Trikha S; Margekar SL; Jatav OP; Ganga PD
J Assoc Physicians India; 2015 Jan; 63(1):12-6. PubMed ID: 26591121
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and metabolic syndrome in patients with NAFLD but without diabetes: effect of a 6 month regime intervention.
Cankurtaran M; Tayfur O; Yavuz BB; Geyik S; Akhan O; Arslan S
Acta Gastroenterol Belg; 2007; 70(3):253-9. PubMed ID: 18074733
[TBL] [Abstract][Full Text] [Related]
8. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
Balakrishnan M; El-Serag HB; Kanwal F; Thrift AP
Dig Dis Sci; 2017 Feb; 62(2):526-533. PubMed ID: 27995401
[TBL] [Abstract][Full Text] [Related]
9. Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart Study.
Cicero AF; D'Addato S; Reggi A; Marchesini G; Borghi C;
Metab Syndr Relat Disord; 2013 Dec; 11(6):412-6. PubMed ID: 23902132
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.
Sirota JC; McFann K; Targher G; Johnson RJ; Chonchol M; Jalal DI
Metabolism; 2013 Mar; 62(3):392-9. PubMed ID: 23036645
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States.
Golabi P; Paik J; Reddy R; Bugianesi E; Trimble G; Younossi ZM
BMC Gastroenterol; 2019 Apr; 19(1):56. PubMed ID: 30991959
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups.
Smits MM; Ioannou GN; Boyko EJ; Utzschneider KM
J Gastroenterol Hepatol; 2013 Apr; 28(4):664-70. PubMed ID: 23286209
[TBL] [Abstract][Full Text] [Related]
13. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
[TBL] [Abstract][Full Text] [Related]
14. Obesity is the only independent factor associated with ultrasound-diagnosed non-alcoholic fatty liver disease: a cross-sectional case-control study.
Lee S; Jin Kim Y; Yong Jeon T; Hoi Kim H; Woo Oh S; Park Y; Soo Kim S
Scand J Gastroenterol; 2006 May; 41(5):566-72. PubMed ID: 16638699
[TBL] [Abstract][Full Text] [Related]
15. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
Du T; Yu X; Yuan G; Zhang J; Sun X
Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
17. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].
Choi SY; Kim D; Kang JH; Park MJ; Kim YS; Lim SH; Kim CH; Lee HS
Korean J Hepatol; 2008 Mar; 14(1):77-88. PubMed ID: 18367860
[TBL] [Abstract][Full Text] [Related]
18. Diastolic dysfunction and cardiovascular risk in old subjects: possible association with NAFLD?
Gianotti G; Cenni A; Bianchi G; Masetti M; Zappoli P; Muscari A; Zoli M;
Arch Gerontol Geriatr; 2014; 58(2):188-95. PubMed ID: 24268461
[TBL] [Abstract][Full Text] [Related]
19. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans.
Yun KE; Shin CY; Yoon YS; Park HS
Atherosclerosis; 2009 Aug; 205(2):533-7. PubMed ID: 19159884
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
